Pinto-Leite R - Search Results

1

Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer.

Pinto-Leite R, Arantes-Rodrigues R, Palmeira C, Colaço B, Lopes C, Colaço A, Costa C, da Silva VM, Oliveira P, Santos L. Pinto-Leite R, et al. Biomed Pharmacother. 2013 Mar;67(2):116-21. doi: 10.1016/j.biopha.2012.11.007. Epub 2012 Dec 26. Biomed Pharmacother. 2013. PMID: 23433853

2

Effect of sirolimus on urinary bladder cancer T24 cell line.

Pinto-Leite R, Botelho P, Ribeiro E, Oliveira PA, Santos L. Pinto-Leite R, et al. J Exp Clin Cancer Res. 2009 Jan 7;28(1):3. doi: 10.1186/1756-9966-28-3. J Exp Clin Cancer Res. 2009. PMID: 19128503 Free PMC article.

3

In vivo and in vitro effects of RAD001 on bladder cancer.

Vasconcelos-Nóbrega C, Pinto-Leite R, Arantes-Rodrigues R, Ferreira R, Brochado P, Cardoso ML, Palmeira C, Salvador A, Guedes-Teixeira CI, Colaço A, Palomino LF, Lopes C, Santos L, Oliveira PA. Vasconcelos-Nóbrega C, et al. Urol Oncol. 2013 Oct;31(7):1212-21. doi: 10.1016/j.urolonc.2011.11.002. Epub 2011 Dec 9. Urol Oncol. 2013. PMID: 22169072

4

The effects of repeated oral gavage on the health of male CD-1 mice.

Arantes-Rodrigues R, Henriques A, Pinto-Leite R, Faustino-Rocha A, Pinho-Oliveira J, Teixeira-Guedes C, Seixas F, Gama A, Colaço B, Colaço A, Oliveira PA. Arantes-Rodrigues R, et al. Lab Anim (NY). 2012 May;41(5):129-34. doi: 10.1038/laban0512-129. Lab Anim (NY). 2012. PMID: 22517091

5

Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.

Pinto-Leite R, Arantes-Rodrigues R, Palmeira C, Gaivão I, Cardoso ML, Colaço A, Santos L, Oliveira P. Pinto-Leite R, et al. J Toxicol Environ Health A. 2012;75(13-15):788-99. doi: 10.1080/15287394.2012.690325. J Toxicol Environ Health A. 2012. PMID: 22788366

6

In vitro and in vivo experimental models as tools to investigate the efficacy of antineoplastic drugs on urinary bladder cancer.

Arantes-Rodrigues R, Colaço A, Pinto-Leite R, Oliveira PA. Arantes-Rodrigues R, et al. Anticancer Res. 2013 Apr;33(4):1273-96. Anticancer Res. 2013. PMID: 23564765 Review.

7

Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer.

Arantes-Rodrigues R, Pinto-Leite R, Ferreira R, Neuparth MJ, Pires MJ, Gaivão I, Palmeira C, Santos L, Colaço A, Oliveira P. Arantes-Rodrigues R, et al. Biomed Pharmacother. 2013 May;67(4):277-84. doi: 10.1016/j.biopha.2013.01.010. Epub 2013 Feb 18. Biomed Pharmacother. 2013. PMID: 23582791

8

Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma.

Arantes-Rodrigues R, Pinto-Leite R, da Costa RG, Colaço A, Lopes C, Oliveira P. Arantes-Rodrigues R, et al. Tumour Biol. 2013 Oct;34(5):2691-6. doi: 10.1007/s13277-013-0820-1. Epub 2013 May 5. Tumour Biol. 2013. PMID: 23645214

9

Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines.

Pinto-Leite R, Arantes-Rodrigues R, Ferreira R, Palmeira C, Colaço A, Moreira da Silva V, Oliveira P, Lara Santos L. Pinto-Leite R, et al. Urol Oncol. 2014 Jan;32(1):41.e11-22. doi: 10.1016/j.urolonc.2013.04.012. Epub 2013 Sep 10. Urol Oncol. 2014. PMID: 24035472

10

Synergistic effect between cisplatin and sunitinib malate on human urinary bladder-cancer cell lines.

Arantes-Rodrigues R, Pinto-Leite R, Fidalgo-Gonçalves L, Palmeira C, Santos L, Colaço A, Oliveira P. Arantes-Rodrigues R, et al. Biomed Res Int. 2013;2013:791406. doi: 10.1155/2013/791406. Epub 2013 Nov 28. Biomed Res Int. 2013. PMID: 24369536 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters